Billiontoone

BillionToOne is a precision diagnostics company focused on developing and commercializing innovative molecular diagnostics tests. They make money by offering advanced genetic testing services, such as their flagship product, UNITY, which provides non-invasive prenatal testing (NIPT) for single-gene disorders. Founded in 2016, the company has rapidly grown due to its unique approach of using proprietary molecular counting technology to improve the accuracy and affordability of genetic tests. BillionToOne aims to make genetic testing accessible and actionable for millions of patients worldwide.

Recent Posts by Billiontoone

1-20 of 121